Cite Filings / KYTX
Feed Companies Filings Check
Sign in

CIK 0001994702 · <br>Emerging growth company

Kyverna Therapeutics, Inc.

Sign in to watch
Ticker
KYTX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
831365441
Phone
5109252492
Business address
5980 HORTON STREET, SUITE 200, EMERYVILLE, CA
Former names
Kyverna Therapeutics, Inc.
Filings Insiders Search text
All 189 Financials 54 Shareholder Meetings 2 Executive Compensation 47 Insider Trading 68 Beneficial Ownership Interest 15 Business Combinations 42 Public Offerings 23 Mutual Funds and ETFs 2 Others 29
›
Filed in
  1. No filings match these filters. Clear filters
  2. SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit 2023-12-15
  3. DRSLTR Other Correspondence Related to Draft Registration Statement 2023-12-13
  4. DRS/A Other Draft Registration Statement 2023-12-13
  5. UPLOAD Other SEC-generated Letter 2023-11-21
  6. DRSLTR Other Correspondence Related to Draft Registration Statement 2023-11-09
  7. DRS/A Other Draft Registration Statement 2023-11-09
  8. D Other Notice of Sales of Unregistered Securities 2023-11-07
  9. UPLOAD Other SEC-generated Letter 2023-11-01
  10. DRS Other Draft Registration Statement 2023-10-05

Page 10 of 10 · 189 filings

First Previous Next Last

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…